Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous vs Single Injection Adductor Canal Block in TKA
NCT06784882Phase 4Recruiting
- Sponsor
- University of California, San Diego
- Start
- Jun 2025
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine in postoperative pain, sponsored by University of California, San Diego. Started Jun 2025; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06784882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06784882.